Team:SJTU-BioX-Shanghai/Results/Test/Overall
From 2013.igem.org
(Difference between revisions)
(→Endogenous fadD Test) |
(→Endogenous fadD Test) |
||
Line 69: | Line 69: | ||
[[File:SJTU13fadD.png]] | [[File:SJTU13fadD.png]] | ||
- | '''Figure 3. Relationship between fadD transcription and light intensity. Bar height represents the relative amount of fadD mRNA. Error bars shows the standard error (s.e.) of parallel groups. Transcription level gradually increases about one-fold. | + | '''Figure 3. Relationship between fadD transcription and light intensity.''' |
+ | <br> | ||
+ | Bar height represents the relative amount of fadD mRNA. Error bars shows the standard error (s.e.) of parallel groups. Transcription level gradually increases about one-fold. | ||
The eligibility of sensor-CRISPRi in precise regulation is confirmed on this genome-residing gene. mRNA amount of fadD increases continuously and steadily when blue light exposure is enlarged. All three properties revealed in plasmid mRFP test are repeated here: | The eligibility of sensor-CRISPRi in precise regulation is confirmed on this genome-residing gene. mRNA amount of fadD increases continuously and steadily when blue light exposure is enlarged. All three properties revealed in plasmid mRFP test are repeated here: | ||
Line 77: | Line 79: | ||
'''·''' The system performance is relatively robust. | '''·''' The system performance is relatively robust. | ||
- | In conclusion, by serially connecting blue light sensor (YF1-FixJ-PFixK2) and CRISPRi, the expression of target gene can be quantitatively related to light signals. Therefore, sen-sor-CRISPRi can be applied where it is necessary to precisely regulate endogenous genes, e.g. in medical therapies and in metabolic optimization | + | In conclusion, by serially connecting blue light sensor (YF1-FixJ-PFixK2) and CRISPRi, the expression of target gene can be quantitatively related to light signals. Therefore, sen-sor-CRISPRi can be applied where it is necessary to precisely regulate endogenous genes, e.g. in medical therapies and in metabolic optimization. |
=='''Red System'''== | =='''Red System'''== |
Revision as of 01:25, 17 January 2014